Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma

Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and safety in patients with uncontrolled asthma.We randomly assigned 1902 patients 12 years of age or older with uncontrolled asthma in a...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Castro, M, Corren, J, Pavord, I, Maspero, J, Wenzel, S, Rabe, K, Busse, W, Ford, L, Sher, L, FitzGerald, J, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, N, Hamilton, J, Swanson, B, Stahl, N, Yancopoulos, G, Teper, A
פורמט: Journal article
שפה:English
יצא לאור: Massachusetts Medical Society 2018

פריטים דומים

פריטים דומים